Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News BioVie Inc BIVI

Alternate Symbol(s):  BIVIW

Healthcare Biotechnology
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to... see more

Current News (NDAQ:BIVI)

BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson's Disease

GlobeNewswire 9 days ago

Join Biovie's Exclusive Live Investor Webinar and Q&A Session on December 9

GlobeNewswire November 19, 2025

Halper Sadeh LLC Encourages BioVie Inc. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire October 24, 2025

BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioVie Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire October 9, 2025

BioVie to Host Live Investor Webinar and Q&A on Oct. 8

GlobeNewswire September 26, 2025

BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes

GlobeNewswire August 13, 2025

BioVie Inc. Announces Closing of $12 Million Public Offering

GlobeNewswire August 11, 2025

BioVie Inc. Announces Pricing of $12 Million Public Offering

GlobeNewswire August 7, 2025

BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology

GlobeNewswire July 24, 2025
View More News ››

Opinion & Analysis (NDAQ:BIVI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BIVI)

Warrants

If you believe in this company, and there's good reason to, suggest you look at the warrants instead of the stock.  Exercisable...
bayoubucks - September 3, 2025

Still holding up

BIVI has dug itself out of the recent hole so it just shows that patient is needed for returns
Tradinghands - October 24, 2024

75% pop!

This started moving on Friday now huge volume with a 75% spike! Friday was the time to buy
Tradinghands - October 21, 2024

BUY BUY BUY BUY BUY

Acuitas fnb takes 44% OWNERSHIP 
Nibinator - July 22, 2024

Up 48 %

but nobody on SH cares . 
divime1 - July 27, 2018

BioVie Receives FDA Clearance

http://www.marketwired.com/press-release/biovie-receives-fda-clearance-ind-application-phase-2a-clinical-trial-refractory-ascites-otcqb...
divime1 - April 3, 2017
View more Bullboard ››

Mullen Group Ltd

Mullen Group Ltd

Mullen Group Ltd. provides a range of trucking and logistics services in Canada and the United States. It operates through ...
View More »

Podcasts